IMS Practical Insights in Novel Immune Therapies in Multiple Myeloma Series
Join us virtually on March 27 and April 10
Are you a hematologist or oncologist treating patients with multiple myeloma? If so, this 90-minute webinar is for you.
These high-impact, 90-minute educational programs will focus on the latest evidence for optimizing treatments for Newly Diagnosed and Relapsed/Refractory patients, including choice of immunotherapy. Key concepts will be covered in presentations by senior faculty, along with practice-relevant case-based discussions.
Registration is complimentary.
Date & Time
East Coast Webinar - NDMM and RRMM
Wednesday, April 1, 2026
6:00 - 7:30 pm EST
West Coast Webinar - NDMM and RRMM
Wednesday, April 8, 2026
6:00 - 7:30 pm PST
Wednesday, April 1, 2026
6:00 - 7:30 pm EST
West Coast Webinar - NDMM and RRMM
Wednesday, April 8, 2026
6:00 - 7:30 pm PST
About the International Myeloma Society
The International Myeloma Society is a professional, scientific, and medical society established to
bring together clinical and experimental scientists involved in the study of myeloma.
The purpose of this society is to promote research, education, clinical studies (including diagnosis
and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical
investigators in the field along with physicians and other healthcare practitioners.
bring together clinical and experimental scientists involved in the study of myeloma.
The purpose of this society is to promote research, education, clinical studies (including diagnosis
and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical
investigators in the field along with physicians and other healthcare practitioners.